Page last updated: 2024-08-21

cyclopentane and Adrenal Cortex Cancer

cyclopentane has been researched along with Adrenal Cortex Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amendola, D; Avena, P; Campana, C; Carpinelli, G; Casaburi, I; Cerquetti, L; Chimento, A; De Luca, A; Domanico, F; Fallo, F; Malivindi, R; Martire, E; Pezzi, V; Rizza, P; Sirianni, R; Stigliano, A; Zolea, F	1

Other Studies

1 other study(ies) available for cyclopentane and Adrenal Cortex Cancer

Article	Year
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo. Oncotarget, 2015, Aug-07, Volume: 6, Issue:22 Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Animals; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Cyclopentanes; DNA Damage; Female; Humans; Male; Mice; Mice, Nude; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction	2015

Article

Year

GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo.

Oncotarget, 2015, Aug-07, Volume: 6, Issue:22

Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Animals; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Cyclopentanes; DNA Damage; Female; Humans; Male; Mice; Mice, Nude; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction

2015